Ownership and insider activity for Neonc Technologies Holdings, Inc. (NTHI): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Price
| Price | $2.99 |
| Market Cap | $78M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2025-11-24 | Heshmatpour Amir F | P-Purchase | 6,000 | $39K |
| 2025-11-21 | Heshmatpour Amir F | P-Purchase | 4,000 | $26K |
| 2025-11-21 | Heshmatpour Amir F | P-Purchase | 20,000 | $120K |
| 2025-11-12 | CHIANG MING-FU (ALAN) | |||
| 2025-11-12 | CHIANG MING-FU (ALAN) | |||
| 2025-11-12 | CHIANG MING-FU (ALAN) | |||
| 2025-11-12 | CHIANG MING-FU (ALAN) | |||
| 2025-11-12 | CHIANG MING-FU (ALAN) | |||
| 2025-11-20 | Neman-Ebrahim Yousha | P-Purchase | 1,100 | $7K |
| 2025-06-05 | Neman-Ebrahim Yousha |
Balance Sheet (10y)
| Year | 2025 |
|---|---|
| Cash & Equivalents | $58729 |
| Short-term Investments | 0 |
| Receivables | 0 |
| Inventory | 0 |
| Total Current Assets | $1.4M |
| Property, Plant & Equipment | $361045 |
| Goodwill | 0 |
| Intangible Assets | $500000 |
| Total Assets | $2.8M |
| Accounts Payable | $7.1M |
| Short-term Debt | $6.0M |
| Total Current Liabilities | $20.0M |
| Long-term Debt | 0 |
| Total Liabilities | $20.3M |
| Retained Earnings | -$112.8M |
| Total Equity | -$17.5M |
| Total Debt | $6.3M |
| Net Debt | $6.3M |
| Working Capital | -$18.7M |
Financial Health
| Debt / Equity | -0.02 |
| Current Ratio | 0.14 |
Profitability
| Return on Equity | 309.09% |
| Return on Invested Capital | 229.42% |
| Return on Assets | -902.18% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Explore sector: Healthcare · Biotechnology
More sections of NTHI: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks